Key facts
- Notable investors include FutureLab & Partners, FutureLab X, Nordic SeaFarm.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Manatee Biomaterials
- ·The full record, as it builds
Funding rounds
No funding rounds for Manatee Biomaterials are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Manatee Biomaterials
Provider of ocean-derived biomaterials intended for sustainable alternatives for circular packaging and product applications. The company focuses on using seaweed from Swedish oceans, refined through sustainable farming practices to create regenerative, traceable, and reliable material, enabling industries to transition away from finite resources and reduce their environmental footprint while promoting ocean ecosystem restoration.
- Sector
- Business Products and Services (B2B)
- HQ
- Strömstad, Sweden
- Founded
- 2024
- Employees
- 4
- Website
- manateebiomaterials.com/
- Ownership
- Privately Held (backing)
Manatee Biomaterials doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Manatee Biomaterials shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Manatee Biomaterials in its N-PORT filings yet. We sweep new filings monthly.